Get complete access to comprehensive company data for Natco Pharma Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Natco Pharma Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 40.00 cr
₹ 35.82 cr
19 Sep 1981
31 Mar 2024
Natco Pharma Limited is an Indian public limited company incorporated on 19 Sep 1981. The company's registered office is situated in Hyderabad, Telangana, India.
The current status of Natco Pharma Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2024 (FY 2023-2024).
Natco Pharma Limited is a company limited by shares with an authorized capital of ₹40.00 cr and a paid-up capital of ₹35.82 cr as per the records maintained by the Ministry of Corporate Affairs (MCA).
Natco Pharma Limited has 9 directors and 2 signatories. The Key Managerial Personnel (KMP) at Natco Pharma Limited include Venkat Ramesh Chekuri as Company Secretary and Veera Venkata Narasimha Appa Rao Sannidhanam as CFO. The directors of the company include Lakshminarayana Bolisetty, Potluri Prasad Sivaramakrishna, Lingarao Donthineni, Vijayabhaskar Dronadula.
The registered office of Natco Pharma Limited is located at Natco House, Road No.2, Banjara Hills Hyderabad Telangana 500034 India in Hyderabad, Telangana, India.
- CIN/LLPIN/FCRN: L24230TG1981PLC003201
- Legal Name: Natco Pharma Limited
- ROC Code: Roc Hyderabad
- Company No.: 003201
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Public
- Listing Status: Listed
- Industry: Agriculture, Pharma
- Date of AGM: 30 Sep 2024
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Natco Pharma Limited |
|---|
Frequently Asked Questions
- agnihotra dakshina murty chavali
- lakshminarayana bolisetty
- lingarao donthineni
- nitin jain
- potluri prasad sivaramakrishna
- rajeev nannapaneni
- suma kantipudi
- veera venkata narasimha appa rao sannidhanam
- venkaiah chowdary nannapaneni
- venkat ramesh chekuri
- vijayabhaskar dronadula